| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,204 |
8,769 |
$1.26M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,703 |
2,403 |
$232K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
188 |
182 |
$29K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
303 |
267 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
224 |
193 |
$16K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
42 |
42 |
$8K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
38 |
38 |
$8K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
46 |
38 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
50 |
47 |
$6K |
| 99307 |
|
217 |
170 |
$2K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
70 |
70 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
181 |
133 |
$523.01 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
906 |
838 |
$321.83 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
46 |
46 |
$243.76 |
| 81003 |
|
14 |
13 |
$2.26 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
19 |
19 |
$0.00 |